Long-term oncological outcomes for young men undergoing radical prostatectomy for localized prostate cancer

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Milonas, Daimantas ^a   Venclovas, Zilvinas ^a   Gudinaviciene, Inga ^a   Zviniene, Kristina ^a   Matjosaitis, Aivaras Jonas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOCHEMICAL PROGRESSION FREE SURVIVAL; BIOCHEMICAL RECURRENCE; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE PROGRESSION FREE SURVIVAL; GLEASON SCORE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RISK FACTOR; SURGICAL MARGIN; AGED; BLOOD; CANCER GRADING; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; SURGICAL ONCOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURGICAL ONCOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85017535195     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/9858923     Document Type: Article

References (23)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward, "Cancer statistics, 2010," CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277-300, 2010.
2. J. Li, R. German, J. King et al., "Recent trends in prostate cancer testing and incidence among men under age of 50," Cancer Epidemiology, vol. 36, no. 2, pp. 122-127, 2012.
3. K. Stamatiou, A. Alevizos, E. Agapitos, and F. Sofras, "Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study," Prostate, vol. 66, no. 12, pp. 1319-1328, 2006.
4. G. Soos, I. Tsakiris, J. Szanto, C. Turzo, P. G. Haas, and B. Dezso, "The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study," European Urology, vol. 48, no. 5, pp. 739-744, 2005.
5. W. A. Sakr, G. P. Haas, B. F. Cassin, J. E. Pontes, and J. D. Crissman, "The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients," Journal of Urology, vol. 150, no. 2, pp. 379-385, 1993.
6. S. Hussein, S. Satturwar, and T. Van der Kwast, "Young-age prostate cancer," Journal of Clinical Pathology, vol. 68, no. 7, pp. 511-515, 2015.
7. D. W. Lin, M. Porter, and B. Montgomery, "Treatment and survival outcomes in young men diagnosed with prostate cancer," Cancer, vol. 115, no. 13, pp. 2863-2871, 2009.
8. N. J. Kinnear, G. Kichenadasse, S. Plagakis et al., "Prostate cancer in men aged less than 50 years at diagnosis," World Journal of Urology, vol. 34, no. 11, pp. 1533-1539, 2016.
9. H. B. Tjaden, D. A. Culp, and R. H. Flocks, "Clinical adenocarcinoma of the prostate in patients under 50 years of age," The Journal of Urology, vol. 93, pp. 618-621, 1965.
10. D. E. Johnson, J. P. Lanieri, and A. G. Ayala, "Prostatic adenocarcinoma occurring in men under 50 years of age," Journal of Surgical Oncology, vol. 4, no. 3, pp. 207-216, 1972.
11. S. J. Freedland, J. C. Presti Jr., C. J. Kane et al., "Do youngermen have better biochemical outcomes after radical prostatectomy?" Urology, vol. 63, no. 3, pp. 518-522, 2004.
12. P. M. Parker, K. R. Rice, J. R. Sterbis et al., "Prostate cancer in men less than the age of 50: a comparisonof race andoutcomes," Urology, vol. 78, no. 1, pp. 110-115, 2011.
13. A. Becker, P. Tennstedt, J. Hansen et al., "Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population. BJU International; 114, no. 1, 38-45, 2014
14. C. Twiss, D. Slova, and H. Lepor, "Outcomes for men younger than 50 years undergoing radical prostatectomy," Urology, vol. 66, no. 1, pp. 141-146, 2005.
15. M. Spahn, S. Joniau, P. Gontero et al., "Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients," European Urology, vol. 58, pp. 1-7, 2010.
16. B. M. Mian, P. Troncoso, K. Okihara et al., "Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone," Journal of Urology, vol. 167, no. 41, pp. 1675-1680, 2002.
17. J. F. Donohue, F. J. Bianco Jr., K. Kuroiwa et al., "Poorly differentiated prostate cancer treated with radical prostatectomy: longterm outcome and incidence of pathological downgrading," Journal of Urology, vol. 176, no. 3, pp. 991-995, 2006.
18. M. Manoharan, V. G. Bird, S. S. Kim, F. Civantos, and M. S. Soloway, "Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8," BJU International, vol. 92, no. 6, pp. 539-544, 2003.
19. S. Serni, L. Masieri, A. Minervini, A. Lapini, G. Nesi, and M. Carini, "Cancer progression after anterograde radical prostatectomy for pathologic Gleason score 8 to 10 and influence of concomitant variables," Urology, vol. 67, no. 2, pp. 373-378, 2006.
20. D. Milonas, R. Baltrimavicius, A. Grybas et al., "Outcome of surgery in locally advanced pT3a prostate cancer," Central European Journal of Urology, vol. 64, no. 4, pp. 209-212, 2011.
21. F. Albright, R. A. Stephenson, N. Agarwal et al., "Prostate cancer risk prediction based on complete prostate cancer family history," Prostate, vol. 75, no. 4, pp. 390-398, 2015.
22. F. Kamangar, G. M. Dores, and W. F. Anderson, "Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world," Journal of Clinical Oncology, vol. 24, no. 14, pp. 2137-2150, 2006.
23. J. L. Donovan, F. C. Hamdy, A. J. Lane et al., "Patientreported outcomes after monitoring, surgery, or radiotherapy for prostate cancer," The New England Journal of Medicine, vol. 375, pp. 1425-1437, 2016.